| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1010752019 |
| P356 | DOI | 10.1186/1476-7120-12-27 |
| P932 | PMC publication ID | 4114095 |
| P698 | PubMed publication ID | 25037453 |
| P5875 | ResearchGate publication ID | 264055246 |
| P2093 | author name string | Mario Marzilli | |
| Frank Lloyd Dini | |||
| Anca Simioniuc | |||
| Maria Chiara Scali | |||
| P2860 | cites work | 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration | Q22306346 |
| The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology | Q26827546 | ||
| Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure) | Q51654594 | ||
| Diagnosis: Biomarkers of cardiovascular outcomes--bonanza or bias? | Q53119636 | ||
| Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients | Q60619537 | ||
| Ultrasound lung comets: the shape of lung water | Q62108061 | ||
| Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations | Q73736775 | ||
| Results of the Predictors of Response to CRT (PROSPECT) trial | Q81219589 | ||
| ??? | Q28267062 | ||
| ??? | Q28306041 | ||
| Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. | Q30500004 | ||
| Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial | Q34003169 | ||
| Biomarkers of cardiovascular disease: molecular basis and practical considerations | Q34526561 | ||
| Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials | Q34614873 | ||
| Myocardial viability and survival in ischemic left ventricular dysfunction | Q35791994 | ||
| American Society of Echocardiography recommendations for use of echocardiography in clinical trials | Q35903513 | ||
| Vasodilators in the treatment of acute heart failure: what we know, what we don't | Q37355110 | ||
| Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography | Q37850875 | ||
| Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association | Q38071269 | ||
| Natriuretic peptide-guided heart failure management | Q38161695 | ||
| Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. | Q38203634 | ||
| BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial | Q38383948 | ||
| Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders | Q38408218 | ||
| Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study | Q39740935 | ||
| Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality | Q42781665 | ||
| N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study | Q43156281 | ||
| N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial | Q43549494 | ||
| Biomarker-guided therapies in heart failure: a forum for unified strategies | Q43881505 | ||
| Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography | Q46072898 | ||
| Effect of PCI on quality of life in patients with stable coronary disease | Q46429326 | ||
| National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure | Q48105140 | ||
| Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are not useful in heart failure management: the art of medicine remains long | Q48190480 | ||
| Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study | Q48194485 | ||
| Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure | Q48355595 | ||
| Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure | Q48390321 | ||
| Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction | Q48563810 | ||
| Stress echo applications beyond coronary artery disease | Q48707474 | ||
| Effects of nebivolol on biomarkers in elderly patients with heart failure | Q48751656 | ||
| The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure | Q48971321 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hormone | Q11364 |
| cardiotonic | Q2938102 | ||
| nerve tissue protein | Q6996861 | ||
| heart failure | Q181754 | ||
| peptide | Q172847 | ||
| Natriuretic peptide, brain type | Q24721416 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 27 | |
| P577 | publication date | 2014-07-18 | |
| P1433 | published in | Cardiovascular Ultrasound | Q15765514 |
| P1476 | title | The potential value of integrated natriuretic peptide and echo-guided heart failure management | |
| P478 | volume | 12 |
| Q58603905 | Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients |
| Q40335788 | Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction |
| Q64883707 | Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2. |
| Q37699042 | Personalized treatment of heart failure with biomarker guidance using a novel disease severity score. |
| Q36625177 | Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: a prospective cohort study |
Search more.